Trending Now
Bridger Aerospace Group Holdings (BAER) stock sparks investor interest and optimism...
Stock of Bridger Aerospace Group Holdings, Inc (NASDAQ:BAER) ended the day on Friday at $7.90, a gain of $3.48 (+78.73%).
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Cybin Inc. (NYSEAMERICAN: CYBN) Announces Second Quarter Results and Preclinical Data...
Cybin Inc. (NYSEAMERICAN: CYBN) has announced its unaudited financial results and business updates for the second quarter ended September 30, 2021.
Cybin released CTB003 preclinical...
MAKE IT MODERN
LATEST REVIEWS
Promising Developments in Waldenstrom Macroglobulinemia Treatment: Mustang Bio’s Latest Clinical Trial...
Mustang Bio, Inc. (Nasdaq: MBIO), a trailblazer in clinical-stage biopharmaceuticals, is making significant strides in cell therapy treatments aimed at curing challenging...
MAKE IT MODERN
PERFORMANCE TRAINING
Emerging Opportunities in the Energy Storage Space (ALB, IGEX, TSLA, FCEL, PLUG, XPEV, BYDDY,...
According to a recent market analysis report from Technavio, the EV battery market could reach $38 billion, with growth from 2021 to...
Vocodia Holdings (VHAI) to Transform Auto Dealership Experience with Groundbreaking AI Service Module Rollout
Vocodia Holdings Corp (VHAI)., a Chicago-based AI software company known for developing practical AI functions, has recently announced a significant milestone in...
Hoth Therapeutics Inc (NASDAQ: HOTH) Starts HT-ALZ Preclinical Trials for Alzheimer’s Disease
Hoth Therapeutics Inc (NASDAQ: HOTH) is a patient-centric biopharma corporation that recently announced that it started preclinical trials for its HT-ALZ product. The study's main...
XS Services at 3-Month High Following Non-Core Asset Sale
If you think all cannabis stocks are crumbling, you’re not seeing Xtraction Services (CSE:XS). Shares of the Los Angeles-based specialty finance company...
Bristol-Myers Squibb Co (NYSE: BMY) Announces Plan to Purchase Turning Point Therapeutics Inc (NASDAQ:...
Bristol-Myers Squibb Co (NYSE: BMY) has announced that it will purchase Turning Point Therapeutics Inc (NASDAQ: TPTX) for $4.1 billion. The latter is currently...
MAKE IT MODERN
